Sophiris Bio, Inc. SPHS
0.00 0.00 (+0.00%)
Apr 24, 2025, 3:47 PM EDT
0.000001 Day range 0.000001
52-week range unavailable
- Market cap
- 317.14K
- Forward P/E
- -0.04
- Volume
- 1.00K
- Open
- 0.000001
- Previous close
- 0.000001
- Day's range
- 0.000001 – 0.000001
- Analysts
- Buy
- Price target
- 3.75 (+374999900.0%)
- Earnings date
- Nov 8, 2019
No chart data for this range yet.
Key statistics
- Price / sales
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- 0
- Total cash
- 0
- Total debt
- 0
- Return on equity
- 0.00%
- 50-day average
- 0.048
- 200-day average
- 0.357941
Analyst view
Consensus: buy
Buy
Price target (mean) 3.75
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy0
- Buy4
- Hold0
- Sell0
- Strong sell0
Next earnings
Nov 8, 2019
Expected Nov 8, 2019. Consensus EPS estimate -0.04.
Financials — quick view
SPHS Revenue — quarterly 0
SPHS Net income — quarterly -959.00K
SPHS EPS — quarterly -0.03
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 8, 2019 | Sep 1, 2019 | -0.07 | — | — | — |
| Aug 9, 2019 | Jun 1, 2019 | -0.10 | — | — | — |
News
Wisr AI Systems Inc. Announces Closing of Amalgamation Stocks That Hit 52-Week Lows On Wednesday
The Daily Biotech Pulse: Cassava Gains On Alzheimer's Presentation, Bristol-Myers Hikes Dividend
71 Biggest Movers From Yesterday
56 Stocks Moving In Thursday's Mid-Day Session
Stocks Which Set New 52-Week Low Today, Wed., Jan. 2, 2019
Stocks Which Set New 52-Week Low Yesterday, Tues., Dec. 18, 2018
Stocks Which Set New 52-Week Low Yesterday, Wed., Nov. 14, 2018
45 Biggest Movers From Yesterday
Your note
Sign in to keep a note on SPHS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BOXER CAPITAL L L C | Beneficial Owner of more than 10% of a Class of Security | Sale | Dec 14, 2014 | 0 |
| EKMAN LARS G | Director | Sale | Dec 17, 2014 | 0 |
| HEPPELL JAMES LESLIE | Director | Sale | Jun 5, 2014 | 0 |
